{"id":"W4381192819","doi":"10.1161/circulationaha.123.064473","title":"Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium","year":2023,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"Duke Clinical Research Institute; National Institutes of Health; CytoSorbents Europe; Daiichi Sankyo Europe; Servier; National Evidence-based Healthcare Collaborating Agency; GlaxoSmithKline; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Medicines Company; Canada Excellence Research Chairs, Government of Canada; Belvoir Media Group; Daiichi-Sankyo; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Intas Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Alnylam Pharmaceuticals; MicroPort; Idorsia Pharmaceuticals; Abbott Vascular; Brigham and Women's Hospital; Kowa Company; Sanofi; Amgen; Pfizer","keywords":"Medicine; Percutaneous coronary intervention; Coronary artery disease; Acute coronary syndrome; Internal medicine; Cardiology; Myocardial infarction; Clopidogrel; Intensive care medicine; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01341903,0.001375985,0.00307442,0.005691574,0.0005471496,0.002799082,0.00324054,0.003365758,0.002117861],"category_scores_gemma":[0.01370331,0.000557279,0.003289294,0.005277598,0.0008584981,0.002574069,0.001964627,0.003779245,0.001418144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003135649,"about_ca_system_score_gemma":0.01721859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004948636,"about_ca_topic_score_gemma":0.007572054,"domain_scores_codex":[0.9955596,0.001162226,0.001457064,0.0003164183,0.001298812,0.0002059062],"domain_scores_gemma":[0.9920162,0.003374241,0.001012449,0.0001998096,0.003134281,0.0002630533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001880975,0.0001203863,0.0003775732,0.1005595,0.0004431974,0.0001791231,0.0003306493,0.0006026334,0.0008858839,0.01116785,0.1007522,0.784393],"study_design_scores_gemma":[0.0001488017,0.0001180038,0.001191892,0.1213955,0.001396169,0.0005187966,0.0002340045,0.0002404655,0.0006248876,0.003820985,0.8702534,0.00005709263],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001406332,0.9910594,0.0005636998,0.00546577,0.0009932775,0.0001425757,0.0001382782,0.00001347949,0.001482855],"genre_scores_gemma":[0.0009916752,0.992828,0.002359282,0.00256205,0.0002772776,0.0001957237,0.0002753989,0.000007939278,0.0005026749],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01341903,"threshold_uncertainty_score":0.0709675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08040670466419762,"score_gpt":0.3618417145907779,"score_spread":0.2814350099265802,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}